Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor ConferenceGlobeNewsWire • 09/14/22
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company's Drug Candidate for the Treatment of Ataxia TelangiectasiaGlobeNewsWire • 09/13/22
Acasti Pharma to Participate at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/12/22
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q1 2023 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022GlobeNewsWire • 08/02/22
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day PodcastNewsfile Corp • 07/07/22
Acasti Pharma, Inc. (ACST) CEO Jan D'Alvise on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 06/21/22
Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication ProgramPRNewsWire • 05/23/22
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All EndpointsGlobeNewsWire • 05/18/22
Update: Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 18thAccesswire • 05/16/22
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16thAccesswire • 05/12/22
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28thGlobeNewsWire • 04/25/22
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of DirectorsGlobeNewsWire • 03/25/22
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in JapanGlobeNewsWire • 03/22/22
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16thGlobeNewsWire • 03/09/22
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/14/22
Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference CallGlobeNewsWire • 02/07/22